Rosella Spadi

2.2k total citations · 1 hit paper
28 papers, 1.4k citations indexed

About

Rosella Spadi is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Rosella Spadi has authored 28 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Oncology, 12 papers in Pulmonary and Respiratory Medicine and 6 papers in Surgery. Recurrent topics in Rosella Spadi's work include Colorectal Cancer Treatments and Studies (7 papers), Pancreatic and Hepatic Oncology Research (7 papers) and Cancer Immunotherapy and Biomarkers (5 papers). Rosella Spadi is often cited by papers focused on Colorectal Cancer Treatments and Studies (7 papers), Pancreatic and Hepatic Oncology Research (7 papers) and Cancer Immunotherapy and Biomarkers (5 papers). Rosella Spadi collaborates with scholars based in Italy, United States and Malaysia. Rosella Spadi's co-authors include Alberto Zaniboni, Alfredo Falcone, Fotios Loupakis, Giuseppe Tonini, Chiara Cremolini, Sara Lonardi, Gianluca Masi, Luca Boni, Lisa Salvatore and Enrico Cortesi and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Oncology and PLoS ONE.

In The Last Decade

Rosella Spadi

27 papers receiving 1.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Initial Therapy with FOLFOXIRI and Bevacizumab for Metastatic Colorectal Cancer

2014 720 citations Fotios Loupakis, Chiara Cremolini et al. New England Journal of Medicine profile →

Peers

Countries citing papers authored by Rosella Spadi

Since Specialization

Citations

This map shows the geographic impact of Rosella Spadi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rosella Spadi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rosella Spadi more than expected).

Fields of papers citing papers by Rosella Spadi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rosella Spadi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rosella Spadi. The network helps show where Rosella Spadi may publish in the future.

Co-authorship network of co-authors of Rosella Spadi

This figure shows the co-authorship network connecting the top 25 collaborators of Rosella Spadi. A scholar is included among the top collaborators of Rosella Spadi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rosella Spadi. Rosella Spadi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	A neuroligin-2-YAP axis regulates progression of pancreatic intraepithelial neoplasia 2024 ·EMBO Reports ·(unknown), Elena Astanina, (unknown), (unknown), Jasna Metović, Rosella Spadi, (unknown), Mauro Papotti, Paola Allavena, Francesco Novelli, (unknown), Paola Cappello, Aldo Scarpa, Rita T. Lawlor, Massimo Di Maïo, Marco Arese, Federico Bussolino	0
2	In pancreatic cancer patients, chemotherapy reshapes the gene expression profile and antigen receptor repertoire of T lymphocytes and enhances their effector response to tumor-associated antigens 2024 ·Frontiers in Immunology ·Silvia Brugiapaglia, (unknown), Claudia Curcio, Maddalena Arigoni, Raffaele Calogero, (unknown), Elisa Genuardi, Rosella Spadi, Maria Antonietta Satolli, Donata Campra, Daniele Giordano, Paola Cappello, Francesca Cordero, Francesco Novelli	1
3	Colorectal cancer with synchronous unresectable liver metastases: resecting the primary tumor improves survival 2023 ·International Journal of Colorectal Disease ·Nicola Leone, Simone Arolfo, Rosella Spadi, (unknown), Roberto Passera, Mario Morino	3
4	Oncological patient management on the territory: The results of a survey in the north-west of Italy 2022 ·Pharmacy Practice ·Francesca Baratta, (unknown), (unknown), (unknown), Pietro Quaglino, Alessandro Comandone, Ada Ala, (unknown), Rosella Spadi, Paola Brusa	1
5	The importance of a multidisciplinary care: community pharmacies as a hub to support oncologic patients with cutaneous reactions due to treatments 2022 ·Italian Journal of Dermatology and Venereology ·(unknown), (unknown), (unknown), Francesca Baratta, Pietro Quaglino, Alessandro Comandone, Ada Ala, (unknown), Rosella Spadi, Paola Brusa	1
6	Immune-Complexome Analysis Identifies Immunoglobulin-Bound Biomarkers That Predict the Response to Chemotherapy of Pancreatic Cancer Patients 2020 ·Cancers ·Giorgia Mandili, (unknown), Giulio Ferrero, Hiroyuki Katayama, Hong Wang, Amin A. Momin, Michela Capello, Daniele Giordano, Rosella Spadi, Maria Antonietta Satolli, Andrea Evangelista, Samir Hanash, Francesca Cordero, Francesco Novelli	9
7	Integrative Analysis of Novel Metabolic Subtypes in Pancreatic Cancer Fosters New Prognostic Biomarkers 2019 ·Frontiers in Oncology ·(unknown), Giulio Ferrero, Giorgia Mandili, Marco Beccuti, Daniele Giordano, Rosella Spadi, Maria Antonietta Satolli, Andrea Evangelista, Hiroyuki Katayama, Hong Wang, Amin A. Momin, Michela Capello, Samir Hanash, Francesco Novelli, Francesca Cordero	30
8	Prognostic and predictive role of EGFR pathway alterations in biliary cancer patients treated with chemotherapy and anti-EGFR 2018 ·PLoS ONE ·Caterina Peraldo‐Neia, Giuliana Cavalloni, Elisabetta Fenocchio, Celeste Cagnazzo, Loretta Gammaitoni, Stefano Cereda, Guglielmo Nasti, Maria Antonietta Satolli, Giuseppe Aprile, Michele Reni, Antonio Avallone, Rosella Spadi, Tiziana Venesio, Vittoria Martin, Claudio Doglioni, Milo Frattini, Massimo Aglietta, Francesco Leone	13
9	Volumetric modulated arc therapy (VMAT) in the treatment of esophageal cancer patients 2018 ·Medical Oncology ·Stefania Martini, Francesca Arcadipane, Paolo Strignano, Rosella Spadi, (unknown), C. Fiandra, Riccardo Ragona, Giorgia Catalano, Maria Antonietta Satolli, Michele Camandona, Renato Romagnoli, Umberto Ricardi, Pierfrancesco Franco	8
10	Pre-operative treatments for adenocarcinoma of the lower oesophagus and gastro-oesophageal junction: a review of the current evidence from randomized trials 2017 ·Medical Oncology ·Pierfrancesco Franco, Francesca Arcadipane, Paolo Strignano, Rosella Spadi, (unknown), Stefania Martini, Giuseppe Carlo Iorio, Maria Antonietta Satolli, Mario Airoldi, Renato Romagnoli, Michele Camandona, Umberto Ricardi	4
11	Current therapeutic strategies for advanced pancreatic cancer: A review for clinicians 2016 ·World Journal of Clinical Oncology ·Rosella Spadi	70
12	Long-term survival after multidisciplinary management of a metastatic sarcomatoid porocarcinoma with repeated exeresis, radiotherapy, chemotherapy and cetuximab: case report and review of literature 2016 ·Italian Journal of Dermatology and Venereology ·Agostino Ponzetti, Simone Ribero, Virginia Caliendo, Rosella Spadi, Giuseppe Macripò, Patrizia Lista	5
13	Intensity-Modulated Radiation Therapy with Simultaneous Integrated Boost Combined with Concurrent Chemotherapy for the Treatment of Anal Cancer Patients: 4-Year Results of a Consecutive Case Series 2015 ·Cancer Investigation ·Pierfrancesco Franco, Massimiliano Mistrangelo, Francesca Arcadipane, Fernando Muñoz, Piera Sciacero, Rosella Spadi, (unknown), (unknown), (unknown), Nadia Rondi, Gianmauro Numico, Riccardo Ragona, Paola Cassoni, Mario Morino, Patrizia Racca, Umberto Ricardi	35
14	Early tumor shrinkage and depth of response predict long-term outcome in metastatic colorectal cancer patients treated with first-line chemotherapy plus bevacizumab: results from phase III TRIBE trial by the Gruppo Oncologico del Nord Ovest 2015 ·Annals of Oncology ·Chiara Cremolini, Fotios Loupakis, (unknown), Sara Lonardi, Gianluca Masi, Lisa Salvatore, Enrico Cortesi, Giovanni Tomasello, Rosella Spadi, Alberto Zaniboni, Giuseppe Tonini, Carlo Barone, S. Vitello, R. Longarini, Andrea Bonetti, Mauro D’Amico, Samantha Di Donato, Cristina Granetto, Luca Boni, Alfredo Falcone	135
15	A phase II, open-label, randomized clinical trial of panitumumab plus gemcitabine and oxaliplatin (GEMOX) versus GEMOX alone as first-line treatment in advanced biliary tract cancer: The Vecti-BIL study. 2015 ·Journal of Clinical Oncology ·Francesco Leone, Donatella Marino, Roberto Filippi, Stefano Cereda, Carmen Belli, Rosella Spadi, Guglielmo Nasti, Massimo Montano, Alessio Amatu, Giuseppe Aprile, Celeste Cagnazzo, Gianpiero Fasola, Salvatore Siena, Libero Ciuffreda, Michele Reni, Massimo Aglietta	3
16	Jaw Osteonecrosis associated with Aflibercept, Irinotecan and Fluorouracil: Attention to Oral District 2015 ·Tumori Journal ·Agostino Ponzetti, (unknown), Rosella Spadi, (unknown), Laura Fanchini, M. Zanini, Libero Ciuffreda, Patrizia Racca	26
17	Initial Therapy with FOLFOXIRI and Bevacizumab for Metastatic Colorectal Cancer breakdown → 2014 ·New England Journal of Medicine ·Fotios Loupakis, Chiara Cremolini, Gianluca Masi, Sara Lonardi, Vittorina Zagonel, Lisa Salvatore, Enrico Cortesi, Gianluca Tomasello, Monica Ronzoni, Rosella Spadi, Alberto Zaniboni, Giuseppe Tonini, Angela Buonadonna, D. Amoroso, Silvana Chiara, Chiara Carlomagno, C. Boni, Giacomo Allegrini, Luca Boni, Alfredo Falcone	720
18	Stereotactic Ablative Radiation Therapy as First Local Therapy for Lung Oligometastases From Colorectal Cancer: A Single-Institution Cohort Study 2014 ·International Journal of Radiation OncologyBiologyPhysics ·Andrea Riccardo Filippi, Serena Badellino, Manuela Ceccarelli, Alessia Guarneri, Pierfrancesco Franco, Chiara Monagheddu, Rosella Spadi, Riccardo Ragona, Patrizia Racca, Umberto Ricardi	59
19	Pilot Clinical Trial on the Efficacy of Prophylactic Use of Vitamin K1–Based Cream (Vigorskin) to Prevent Cetuximab-Induced Skin Rash in Patients With Metastatic Colorectal Cancer 2013 ·Clinical Colorectal Cancer ·(unknown), Agostino Ponzetti, Rosella Spadi, Laura Fanchini, M. Zanini, (unknown), Cristina Sonetto, Libero Ciuffreda, Patrizia Racca	29
20	Hemolytic uremic syndrome induced by infusion of oxaliplatin: A case report 2011 ·Tumori Journal ·Patrizia Racca, Rosella Spadi, (unknown), Laura Fanchini, Giuliana Ritorto, Laura Ferrari, (unknown), Patrizia Lista, Libero Ciuffreda	8

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact